MRPS9 antisense RNA 1 (MRPS9-AS1)

MRPS9 antisense RNA 1 (MRPS9-AS1) is a long noncoding RNA gene. Unlike protein-coding genes, lncRNAs like MRPS9-AS1 do not produce proteins but may have regulatory roles in gene expression. MRPS9-AS1 is also known as UTAT33 or uterine endometrial carcinoma-associated transcript 33, suggesting an initial discovery context in endometrial cancer, but there is limited or no detailed functional characterization available in public databases. It is distinct from MRPS9, which encodes a mitochondrial ribosomal protein; MRPS9-AS1 is instead its antisense RNA and does not encode a mitochondrial ribosomal protein itself[4]. Explanation and context: - MRPS9-AS1 is frequently confused with MRPS9 (mitochondrial ribosomal protein S9), a protein-coding gene involved in mitochondrial translation[2][3][5]. However, MRPS9-AS1 itself is an *antisense RNA*, classified as a lncRNA[4]. - There is currently **no evidence** that MRPS9-AS1 is a *therapeutic target* (receptor, enzyme, etc.), nor that it interacts with any known drugs or serves as a biomarker. - The information on its function, disease role, or clinical value is limited or missing in the current literature and major genomic resources[4]. If you are seeking structured drug target information, MRPS9-AS1 does not qualify as a classical target. There is nothing known to be therapeutically actionable, and it should not be confused with the protein-coding MRPS9 gene.

Other names

UTAT33uterine endometrial carcinoma-associated transcript 33